Form 4: Director Slager Defers EMN Fees into Phantom Stock

Eastman Chemical Director Donald W. Slager deferred a portion of his annual retainer fees into 487 phantom stock units, increasing his total beneficial ownership to 1,267 units.

Summary

• Donald W. Slager, a Director of Eastman Chemical Co. (EMN), acquired 487 phantom stock units on October 7, 2025.
• These units were acquired through the automatic deferral of a portion of his annual director's retainer fees, which would otherwise have been paid in cash.
• Each phantom stock unit has a value equal to the market value of one share of Eastman Chemical common stock and is payable only in cash after the termination of service as a director.
• Following this transaction, Mr. Slager beneficially owns 1,267 phantom stock units.
• This total includes 19 units credited since April 7, 2025, as hypothetical reinvestment of dividend equivalents.

Sentiment

Score: 7

Explanation: The transaction is a routine, pre-planned deferral of director compensation into equity-linked units, indicating continued alignment of director interests with shareholders. It's a neutral to slightly positive signal of commitment.

Positives

• Director Slager's decision to defer cash fees into phantom stock units demonstrates alignment of his interests with long-term shareholder value.
• The increase in phantom stock unit holdings reflects continued commitment to the company's performance.

Negatives

• No explicit negatives are present in this Form 4 filing, which primarily reports a routine compensation deferral.

Risks

• The value of the phantom stock units is tied to the market value of Eastman Chemical common stock, exposing the deferred compensation to market fluctuations.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the nature of the phantom stock units being payable upon termination of service.

Industry Context

This is a routine insider transaction related to director compensation. It does not provide broader industry trends or competitive analysis. Such deferral plans are common in publicly traded companies to align director interests with shareholders.

Comparison to Industry Standards

• Director compensation deferral into equity-linked instruments like phantom stock units is a standard practice in corporate governance across various industries, including chemicals, to align director incentives with long-term company performance.
• Many S&P 500 companies utilize similar deferred compensation plans for non-employee directors, often linking the value to common stock performance.

Corporate Governance

Related Party Transactions

• The transaction involves a director deferring compensation into company-issued phantom stock units, which is a standard, disclosed compensation arrangement between a related party (director) and the company.

Stakeholder Impact

• Shareholders: Potentially positive, as it aligns director incentives with long-term stock performance.
• Director (Donald W. Slager): His compensation is now partially tied to the future performance of EMN stock.

Next Steps

• The phantom stock units will be payable in cash after the termination of service as a director.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned deferral of director compensation into phantom stock units. While it indicates continued alignment of director interests with shareholder value, it does not present new information that would fundamentally alter the investment thesis for Eastman Chemical Co. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not provide a strong catalyst for a 'buy' or 'sell' decision.

Keywords

Eastman Chemical, EMN, Form 4, Insider Transaction, Phantom Stock, Director Compensation, Stock Deferral, Beneficial Ownership